Claritev Corp (NYSE: CTEV)

Sector: Healthcare Industry: Health Information Services CIK: 0001793229
Market Cap 529.75 Mn
P/B -5.20
P/E -1.55
P/S 0.56
ROIC (Qtr) -0.08
Div Yield % 0.00
Rev 1y % (Qtr) 6.71
Total Debt (Qtr) 4.65 Bn
Debt/Equity (Qtr) -45.69

About

MultiPlan Corp, also known by its stock symbol MPLN, operates in the U.S. healthcare industry, providing data analytics and technology-enabled solutions aimed at increasing affordability, efficiency, and fairness. The company's main business activities encompass out-of-network cost management, payment and revenue integrity, business-to-business healthcare payments, and other services for payors such as health insurers, self-insured employers, federal and state government-sponsored health plans, and other health plan sponsors. MultiPlan's revenue...

Read more

Price action

Investment thesis

Bull case

  • Healthy cash reserves of 50.65M provide 2.60x coverage of short-term debt 19.52M, demonstrating strong liquidity position and minimal refinancing risk.
  • Robust tangible asset base of 618.75M provides 14.02x coverage of working capital 44.14M, indicating strong operational backing.
  • Retained earnings of (2.35B) represent substantial 23.07x of equity (101.83M), indicating strong internal capital generation.
  • Cash position of 50.65M represents healthy 1.15x of working capital 44.14M, demonstrating strong operational liquidity.
  • Tangible assets of 618.75M provide robust 2.90x coverage of current liabilities 213.32M, showing strong asset backing.

Bear case

  • Operating cash flow of 17.62M barely covers its investment activities of (116.79M), with a coverage ratio of -0.15, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Free cash flow of (112.50M) provides weak coverage of capital expenditures of 130.13M, with a -0.86 ratio suggesting additional external financing needs for growth initiatives.
  • The company's operating cash flow of 17.62M shows concerning coverage of stock compensation expenses of 26.84M, with a 0.66 ratio indicating potential earnings quality issues.
  • Operating cash flow of 17.62M provides minimal -0.16x coverage of tax expenses of (110.61M), suggesting potential tax planning inefficiencies or unsustainable tax positions.
  • Operating earnings of (78.43M) show weak coverage of depreciation charges of 445.95M, with a -0.18 ratio indicating high capital intensity and potential reinvestment needs.

Product and Service Breakdown of Revenue (2024)

Product and Service Breakdown of Revenue (2024)

Peer comparison

Companies in the Health Information Services
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TEM Tempus AI, Inc. 45.63 Bn -223.83 41.29 1.34 Bn
2 GEHC GE HealthCare Technologies Inc. 38.75 Bn 19.85 2.19 10.28 Bn
3 VEEV Veeva Systems Inc 37.30 Bn 43.36 12.11 0.09 Bn
4 DOCS Doximity, Inc. 7.81 Bn 30.87 12.57 0.01 Bn
5 BTSG BrightSpring Health Services, Inc. 7.70 Bn 59.42 0.62 2.70 Bn
6 HQY Healthequity, Inc. 7.32 Bn 38.14 5.67 1.03 Bn
7 WAY Waystar Holding Corp. 5.00 Bn 44.97 4.81 1.25 Bn
8 PRVA Privia Health Group, Inc. 2.79 Bn 153.67 1.37 0.01 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.02 2.77
EV to Cash from Ops. EV/CFO 290.04 -10.86
EV to Debt EV to Debt 1.10 161.93
EV to EBIT EV/EBIT -65.18 -106.48
EV to EBITDA EV/EBITDA 11.59 4.22
EV to Free Cash Flow [EV/FCF] EV/FCF -45.44 7.46
EV to Market Cap EV to Market Cap 9.65 -14.93
EV to Revenue EV/Rev 5.38 1.76
Price to Book Value [P/B] P/B -5.20 10.57
Price to Earnings [P/E] P/E -1.55 147.14
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 -8.65
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 5.00
Dividend per Basic Share Div per Share (Qtr) 0.00 0.04
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 4.57
Interest Coverage Int. cover (Qtr) -0.21 -584.72
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -9.32 -24.09
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -47.88 172.48
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 -1.05
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 95.17 -17.73
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 150.51 39.85
EBIT Growth (1y) % EBIT 1y % (Qtr) 93.91 -38.83
EBT Growth (1y) % EBT 1y % (Qtr) 72.02 -4.52
EPS Growth (1y) % EPS 1y % (Qtr) 78.07 2.60
FCF Growth (1y) % FCF 1y % (Qtr) -326.36 -48.57
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 1.55 5.49
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.19 0.66
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.03
Cash Ratio Cash Ratio (Qtr) 0.24 1.87
Current Ratio Curr Ratio (Qtr) 1.21 3.27
Debt to Equity Ratio Debt/Equity (Qtr) -45.69 -0.43
Interest Cover Ratio Int Coverage (Qtr) -0.21 -584.72
Times Interest Earned Times Interest Earned (Qtr) -0.21 -584.72
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 38.60 -435.80
EBIT Margin % EBIT Margin % (Qtr) -8.25 -464.70
EBT Margin % EBT Margin % (Qtr) -47.56 -461.74
Gross Margin % Gross Margin % (Qtr) 74.70 44.03
Net Profit Margin % Net Margin % (Qtr) -35.90 -468.01